Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BiolibertyCompany profile Soft robotics and therapy software for rehabilitation after neurological injury. Soft robotics and therapy software for rehabilitation after neurological injury. | £1.5M | Pre-Series AUndisclosed | Healthtech | United Kingdom | Investors | |
| IF ISAK Fragrances makes perfumes, attars and home fragrance products. | Undisclosed | Amazon Propel Season 4 grantUndisclosed | Consumer | India | Investors | |
| A Auric sells Ayurveda-inspired wellness products through ecommerce. | Undisclosed | Amazon Propel Season 4 grantUndisclosed | Consumer | India | Investors | |
| FM Fix My CurlsCompany profile Fix My Curls makes haircare products for naturally wavy, curly and coily hair. Fix My Curls makes haircare products for naturally wavy, curly and coily hair. | Undisclosed | Amazon Propel Season 4 grantUndisclosed | Consumer | India | Investors | |
| SA Scale AICompany profile Scale AI provides training data and builds AI applications for model developers, enterprises and government customers. Scale AI provides training data and builds AI applications for model developers, enterprises and government customers. | Undisclosed | Strategic equity investment including shareholder liquidityUndisclosed | AI | United States | Investors | |
NscaleCompany profile Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference | ≤$105M | Macquarie senior credit facilityUndisclosed | AI | United Kingdom | Investors | |
| AB Aoxi BiopharmaceuticalCompany profile Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells. Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells. | CN¥12M | Grant-to-equity project support disclosed May 2025Undisclosed | Biotech | China | Investors Undisclosed | |
| M Chemical-free mosquito traps for homes, businesses and outdoor spaces. | Undisclosed | Seeds of Bravery programme awardsUndisclosed | Hardware | United States | Investors | |
VolareCompany profile Volare converts food-industry side streams into insect protein, oil and fertiliser for feed and agriculture. Volare converts food-industry side streams into insect protein, oil and fertiliser for feed and agriculture. | €26M | Undisclosed | Foodtech | Finland | Investors | |
| O OmnioCompany profile Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. | ~€4.3M | Funding roundUndisclosed | Biotech | Sweden | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.